10/24/2024
3:44 PM | BlackRock, Inc. (Filed by)
Theravance Biopharma (Subject)
| Form SC 13G/A | |
09/23/2024
5:05 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
5:02 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
4:42 PM | BAUPOST GROUP LLC/MA (Filed by)
Theravance Biopharma (Subject)
| Form SC 13G/A | |
08/22/2024
7:03 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:05 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:06 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/22/2024
7:07 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:09 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
5:02 PM | Samaha Eli (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
5:05 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
3:57 PM | Theravance Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/12/2024
5:15 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:02 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:04 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:06 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:08 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:10 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
5:01 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
5:26 AM | Theravance Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024
5:01 PM | Smaldone Alsup Laurie (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
5:02 PM | BROSHY ERAN (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
5:04 PM | Grant Jeremy T (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
5:06 PM | GRAY SUSANNAH (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
5:09 PM | MITCHELL DEAN J (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
5:10 PM | O'Connor Donal (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
5:12 PM | PAKIANATHAN DEEPIKA (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
3:15 PM | Theravance Biopharma (Filer)
| Form DEF 14A | |
04/04/2024
5:09 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
5:11 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
5:13 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
5:15 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
5:17 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:06 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:01 AM | Theravance Biopharma (Subject)
Weiss Asset Management LP (Filed by)
| Form SC 13D/A | |
02/22/2024
7:04 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:06 PM | GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:08 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:10 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:11 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:14 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here |
02/16/2024
7:12 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/16/2024
5:16 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
5:07 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
5:01 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2023
5:06 PM | Grant Jeremy T (Reporting)
Theravance Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/26/2023
5:09 PM | Grant Jeremy T (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
4:10 PM | Theravance Biopharma (Filer)
| Form DEFA14A | |
12/21/2023
4:06 PM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
5:07 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
5:10 PM | GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
5:11 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
5:14 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
5:16 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
5:16 PM | GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2023
3:10 PM | GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023
3:46 PM | Theravance Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
3:53 PM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
